THE PRODUCTION OF PARTHENOGENETIC MAMMALIAN EMBRYOS AND THEIR USE IN BIOLOGICAL RESEARCH

1. The eggs of many mammalian species show signs of early parthenogenetic development as they age after ovulation and oocytes may form transplantable terato-carcinomas. These cases of apparently spontaneous parthenogenetic development suggest that the cells of the female germ line have an inherent tendency to divide and differentiate. 2. The ovulated eggs of virgin female mammals may be stimulated to start parthenogenetic development by a wide variety of treatments. Most of these damage the egg so that it does not develop beyond the 4 cell stage. However if the eggs are exposed to electrical activation, hyaluronidase treatment, or temperature shock then in many cases they will develop into blastocysts. 3. These blastocysts may be either haploid or diploid. Haploid blastocysts may be formed either by the egg extruding the nucleus of the second polar body or by the egg dividing in half, so that the female pronucleus is in one cell and the nucleus of the second polar body is in another cell. Diploid blastocysts are formed by the retention of the nucleus of the second polar body within the egg. The way in which the egg develops may be controlled by altering the osmolarity of the culture medium, the age of the egg at the time of activation, or the strain of animal used. 4. The action of the sperm on the egg can be defined by comparing the events of normal fertilization and parthenogenetic activation. Both these stimuli cause the egg to expose binding sites for Concanavalin A to synthesize DNA and to divide. However, the release of cortical granules, which occurs after fertilization, does not appear to be induced by parthenogenetic activation, and it is significant that parthenogenones lack the sperm nucleus and mitochondria. 5. The majority of parthenogenones die soon after implantation. Death at this time occurs with parthenogenones obtained from the activated eggs of both inbred and outbred stocks. Death might be caused by recessive lethal mutations or by extra-genetic effects of the maternal chromosomes. 6. Parthenogenones contain endogenous A-type particles which shows that these bodies are inherited through the female germ line. 7. Parthenogenones may in the future provide both a method for chromosome mapping and a source of haploid cells. At present the use of mammalian parthenogenones in biological research is restricted by the heavy embryonic losses which occur around the time of implantation. This means that the role of the sperm, gene activity and virus expression must be studied during a very limited period. Part of the mortality before implantation is the consequence of the damage which the egg suffers during activation and it should be possible to reduce this loss by improving the techniques for activation. It may also be possible to increase the quantity of cells derived from haploid and diploid mammalian embryos by deriving teratocarcinomas from them.